News

Malaria Researchers Wait for Industry to Join Fight

Science  17 Mar 2000:
Vol. 287, Issue 5460, pp. 1956-1958
DOI: 10.1126/science.287.5460.1956

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

A huge toll of illness and death, a dire need for new treatments, and rapid scientific progress are inspiring researchers to battle malaria. But most drug companies balk at investing in what they see as a Third World disease. Some researchers think it's time for the government to step in, perhaps with tax breaks and longer patents for certain drugs on the condition that the revenue be used for new antimalarials.

Related Content